Gemcitabine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Gemcitabine and local guidelines before prescribing.

Antimetabolite cytotoxic

Mechanism

Nucleoside analogue.

Uses

Pancreatic, lung, bladder, ovarian and breast cancers.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Myelosuppression, flu-like symptoms, rash, haemolytic uraemic syndrome, pneumonitis.

Interactions

Radiotherapy toxicity increased.

Contraindications and cautions

Severe renal impairment

Monitoring

FBC, U&E, LFT

Pregnancy and breastfeeding

Contraindicated

Renal and hepatic impairment

Reduce dose in hepatic and renal impairment

Overdose and reversal

Supportive

Special advice

FBC before each dose; stop if HUS.

More from the textbook: uses, cautions and other points
Where it is discussed in the book